Tag results:

p21

Cucurbitacin E Triggers Cellular Senescence in Colon Cancer Cells via Regulating the miR-371b-5p/TFAP4 Signaling Pathway

[Journal of Agricultural and Food Chemistry] Cucurbitacin E (CE) belongs to the triterpenoids and has received substantial attention for its antineoplastic property. The authors revealed that CE significantly induced cellular senescence in colorectal cancer cells.

IRE1α Drives Lung Epithelial Progenitor Dysfunction to Establish a Niche for Pulmonary Fibrosis

[American Journal of Physiology-Lung Cellular and Molecular Physiology] Kinase inhibitor of IRE1α treatment increased the differentiation of Krt19CreERT2-lineage-traced damage-associated transient progenitors (DATPs) into type 1 alveolar epithelial cells after bleomycin injury, indicating that relief from IRE1α signaling enabled DATPs to exit the transitional state.

Olaparib Induced Senescence is Bypassed through G2/M Checkpoint Override in Olaparib Resistant Prostate Cancer

[Molecular Cancer therapeutics] Investigators characterized responses to olaparib in sensitive LNCaP and C4-2B cells and developed two olaparib resistant derivative cell line models from each. In LNCaP and C4-2B cells, they found that olaparib induced massive DNA damage, leading to activation of the G2/M checkpoint, activation of p53, and cell cycle arrest.

Melatonin Is a Potential Oncostatic Agent to Inhibit HepG2 Cell Proliferation through Multiple Pathways

[Heliyon] Researchers investigated melatonin's antitumor molecular mechanisms to inhibit the proliferation of HepG2 cells.

The Landscape of Human Tissue and Cell Type Specific Expression and Co-Regulation of Senescence Genes

[Molecular Neurodegeneration] The authors performed an integrative gene network analysis of bulk and single-cell RNA-seq data in non-diseased human tissues to investigate senescence gene co-expression signatures and their cell-type specificity.

A Novel PAK4 Inhibitor Suppresses Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine

[Translational Oncology] Researchers developed a new PAK4 inhibitor, PAKib and tested its effect on pancreatic cancer (PC) cell growth in vitro and in a syngeneic mouse model of PC.

Popular